Product Information
FEIRZA 1.5 MG-30 MCG TABLET is a generic product labeled by Xiromed LLC, priced at $0.1419 per EA under NDC 70700030985. Its NADAC has been published 60 times since Aug 13, 2025.
FDA first approved this application on Feb 20, 2015. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
FEIRZA 1.5 MG-30 MCG TABLET
Norethindrone Acetate and Ethinyl Estradiol Tablets USP, 1.5 mg/30 mcg and Ferrous Fumarate Tablets, 75 mgManufacturer
Xiromed LLCNDC
70700030985
Classification
Generic
Dosage Form
KIT
Effective Date
9/23/2026
Approval Type
Generic (ANDA)
FDA Application
ANDA202741FDA Approved
2/20/2015
TE Code
AB
On Market Since
1/29/2025
Price Statistics
The NADAC for FEIRZA 1.5 MG-30 MCG TABLET has been published 60 times since Aug 13, 2025, and over the history we have for it it has declined 4.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1419 per EA |
|---|---|
| All-time high | $0.1575 (Nov 12, 2025) |
| All-time low | $0.1303 (Feb 18, 2026) |
| 52-week high | $0.1575 |
| 52-week low | $0.1303 |
| Median price | $0.1429 |
| Average price | $0.1440 |
| Largest weekly change | -5.5% (Jan 21, 2026) |
| Weeks tracked | 60 |
| Tracking since | Aug 13, 2025 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Norethindrone Acetate and Ethinyl Estradiol Tablets USP, 1.5 mg/30 mcg and Ferrous Fumarate Tablets, 75 mg market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Xiromed LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Norethindrone Acetate and Ethinyl Estradiol Tablets USP, 1.5 mg/30 mcg and Ferrous Fumarate Tablets, 75 mg market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of FEIRZA 1.5 MG-30 MCG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for FEIRZA 1.5 MG-30 MCG TABLET, manufactured by Xiromed LLC, is $0.1419 per EA (NDC 70700030985), effective Sep 30, 2026.
How has the price of FEIRZA 1.5 MG-30 MCG TABLET changed over time?
Over the history we have for it, the NADAC for FEIRZA 1.5 MG-30 MCG TABLET has declined 4.4%. It has been tracked across 60 weekly CMS publications since Aug 13, 2025.
What are the highest and lowest recorded NADAC prices for FEIRZA 1.5 MG-30 MCG TABLET?
Since Aug 13, 2025, the NADAC for FEIRZA 1.5 MG-30 MCG TABLET has ranged from a low of $0.1303 (Feb 18, 2026) to a high of $0.1575 (Nov 12, 2025), with a median of $0.1429 per EA.
Are there cheaper alternatives to FEIRZA 1.5 MG-30 MCG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of FEIRZA 1.5 MG-30 MCG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures FEIRZA 1.5 MG-30 MCG TABLET?
FEIRZA 1.5 MG-30 MCG TABLET (NDC 70700030985) is labeled by Xiromed LLC, and CMS classifies it as a generic product.